Harmac Medical Products

Harmac Medical Products

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Harmac Medical Products is a privately held, revenue-generating CDMO with over 45 years of experience in the medical device industry. Operating from four global manufacturing sites in the US, Mexico, and Ireland, the company leverages vertical integration, lean manufacturing, and automation to produce Class I, II, and III devices for a wide range of therapeutic areas. Its core value proposition is acting as a strategic partner to both startups and global companies, offering scalable solutions to accelerate time-to-market while ensuring high quality and regulatory compliance.

Fluid ManagementWound CareOncologyOphthalmicDiagnosticRespiratoryExtracorporeal

Technology Platform

Integrated CDMO platform offering Design for Manufacturing/Assembly (DFM/DFA), vertical integration, automation, lean manufacturing, process validation, packaging/sterilization management, and value engineering for single-use medical devices.

Opportunities

Strong growth is driven by the trend towards outsourcing in the medical device industry, increasing demand for single-use devices, and the need for resilient, multi-geography supply chains.
Expansion in high-growth sectors like cell therapy, diagnostics, and oncology presents significant new business potential.

Risk Factors

Key risks include dependency on client pipeline success, intense competition in the CDMO space pressuring margins, and the ever-present operational risk of quality failures or regulatory non-compliance given the complex nature of Class II/III device manufacturing.

Competitive Landscape

Harmac competes in the fragmented but competitive global medical device CDMO market against large public players (e.g., Flex, Jabil), specialized private manufacturers, and in-house production by device OEMs. Its differentiation lies in full-service vertical integration, a focus on single-use devices, and a strategic multi-national manufacturing footprint.